Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.16 - $0.47 $67,703 - $198,879
-423,148 Reduced 85.24%
73,284 $13,000
Q3 2021

Nov 16, 2021

BUY
$1.21 - $1.8 $24,046 - $35,771
19,873 Added 4.17%
496,432 $825,000
Q2 2021

Aug 16, 2021

BUY
$1.56 - $1.98 $629,109 - $798,484
403,275 Added 550.29%
476,559 $796,000
Q2 2019

Aug 09, 2019

SELL
$0.39 - $0.7 $82,414 - $147,924
-211,320 Reduced 74.25%
73,284 $29,000
Q1 2019

May 14, 2019

BUY
$0.43 - $0.68 $31,512 - $49,833
73,284 Added 34.68%
284,604 $160,000
Q4 2018

Feb 14, 2019

BUY
$0.39 - $0.7 $24,733 - $44,394
63,420 Added 42.88%
211,320 $84,000
Q2 2018

Aug 08, 2018

BUY
$1.66 - $3.82 $245,514 - $564,978
147,900 New
147,900 $326,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.